Highlander Capital Management’s Colgate-Palmolive CL Stock Holding History

Highlander Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$163K	Hold	1,814	–	–	0.06%	226
2023 Q4	$145K	Hold	1,814	–	–	0.05%	241
2023 Q3	$129K	Hold	1,814	–	–	0.05%	243
2023 Q2	$140K	Hold	1,814	–	–	0.06%	195
2023 Q1	$136K	Hold	1,814	–	–	0.07%	195
2022 Q4	$143K	Hold	1,814	–	–	0.07%	177
2022 Q3	$127K	Hold	1,814	–	–	0.07%	179
2022 Q2	$145K	Hold	1,814	–	–	0.08%	171
2022 Q1	$138K	Hold	1,814	–	–	0.06%	181
2021 Q4	$155K	Hold	1,814	–	–	0.07%	168
2021 Q3	$137K	Hold	1,814	–	–	0.07%	181
2021 Q2	$148K	Hold	1,814	–	–	0.07%	180
2021 Q1	$143K	Hold	1,814	–	–	0.07%	172
2020 Q4	$155K	Hold	1,814	–	–	0.09%	158
2020 Q3	$140K	Hold	1,814	–	–	0.08%	165
2020 Q2	$133K	Hold	1,814	–	–	0.08%	172
2020 Q1	$120K	Buy	1,814 +95	+6%	+$6.7K	0.09%	182
2019 Q4	$118K	Hold	1,719	–	–	0.07%	198
2019 Q3	$126K	Hold	1,719	–	–	0.08%	201
2019 Q2	$123K	Hold	1,719	–	–	0.07%	213
2019 Q1	$118K	Hold	1,719	–	–	0.07%	214
2018 Q4	$102K	Hold	1,719	–	–	0.07%	227
2018 Q3	$115K	Hold	1,719	–	–	0.06%	236
2018 Q2	$111K	Hold	1,719	–	–	0.06%	247
2018 Q1	$118K	Hold	1,719	–	–	0.07%	235
2017 Q4	$130K	Hold	1,719	–	–	0.1%	212
2017 Q3	$125K	Sell	1,719 -600	-26%	-$43.2K	0.1%	225
2017 Q2	$171K	Hold	2,319	–	–	0.13%	178
2017 Q1	$170K	Hold	2,319	–	–	0.14%	172
2016 Q4	$152K	Hold	2,319	–	–	0.13%	185
2016 Q3	$172K	Hold	2,319	–	–	0.15%	170
2016 Q2	$170K	Hold	2,319	–	–	0.16%	169
2016 Q1	$164K	Hold	2,319	–	–	0.15%	168
2015 Q4	$154K	Buy	2,319 +606	+35%	+$40.3K	0.14%	175
2015 Q3	$108K	Buy	1,713 +6	+0.4%	+$392	0.1%	229
2015 Q2	$112K	Sell	1,707 -394	-19%	-$26.7K	0.1%	224
2015 Q1	$146K	Buy	2,101 +6	+0.3%	+$415	0.13%	188
2014 Q4	$145K	Buy	2,095 +6	+0.3%	+$405	0.12%	192
2014 Q3	$136K	Buy	2,089 +6	+0.3%	+$396	0.13%	179
2014 Q2	$142K	Buy	2,083 +5	+0.2%	+$335	0.13%	185
2014 Q1	$135K	Buy	2,078 +6	+0.3%	+$378	0.13%	183
2013 Q4	$135K	Buy	2,072 +6	+0.3%	+$384	0.13%	191
2013 Q3	$123K	Buy	2,066 +6	+0.3%	+$355	0.12%	196
2013 Q2	$118K	Buy	+2,060	New	+$122K	0.12%	193

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Highlander Capital Management's CL Position: Q1 2024 in Review

Highlander Capital Management held its Colgate-Palmolive (CL) position steady in Q1 2024 at 1,814 shares worth $163K. The position accounts for 0.06% of the portfolio, ranked #226.

Highlander Capital Management first reported a position in CL in Q2 2013 and has held it in 44 quarters since. The position peaked at $172K in Q3 2016. 1,766 funds tracked by Wall St. Rank hold CL as of Q1 2024.

Highlander Capital Management held 1,814 shares of Colgate-Palmolive worth $163K as of Q1 2024.
Highlander Capital Management left its Colgate-Palmolive share count unchanged in Q1 2024.
Colgate-Palmolive made up 0.06% of Highlander Capital Management's portfolio in Q1 2024, its #226 holding.
Highlander Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 44 quarters since.
Highlander Capital Management's Colgate-Palmolive position peaked at $172K in Q3 2016.
1,766 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.